Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • WHEELER CM
    • KITCHENER H
    • TEIXEIRA JC
    • SKINNER SR
    • JAISAMRARN U
    • LIMSON G
    • ROMANOWSKI B
    • AOKI FY
    • SCHWARZ TF
    • POPPE WAJ
    • XAVIER BOSCH F
    • CASTELLSAGUE X
    • HARPER DM
    • HUH W
    • HARDT K
    • ZAHAF TK
    • DESCAMPS D
    • STRUYF F
    • DUBIN G
    • LEHTINEN M
    • PROF Suzanne Garland Wark
    • SZAREWSKI A
    • PAAVONEN J
    • NAUD P
    • SALMERON J
    • CHOW S-N
    • APTER D

Published in

  • Lancet Oncology

Time

Date/time value

  • 2012

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(11)70287-X

Additional Document Info

Parent Title

  • LANCET ONCOLOGY

Volume

  • 13

Issue

  • 1

Publisher

  • Lancet